Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis: a nationwide cohort study

Mathias Due Buron, Thor Ameri Chalmer, I Barzinji, J R Christensen, M K B Christensen, V Hansen, Zsolt Illés, Henrik Boye Jensen, Matthias Kant, T. Petersen m.fl.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Original languageEnglish
Publication date12. Sep 2019
Publication statusPublished - 12. Sep 2019
EventECTRIMS 2019: 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis - Stockholm, Sweden
Duration: 11. Sep 201913. Sep 2019
Conference number: 35
https://www.ectrims-congress.eu/2019.html

Conference

ConferenceECTRIMS 2019
Number35
CountrySweden
CityStockholm
Period11/09/201913/09/2019
Internet address

Cite this

Buron, M. D., Chalmer, T. A., Barzinji, I., Christensen, J. R., Christensen, M. K. B., Hansen, V., ... Petersen m.fl., T. (2019). Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis: a nationwide cohort study. Poster session presented at ECTRIMS 2019, Stockholm, Sweden.
Buron, Mathias Due ; Chalmer, Thor Ameri ; Barzinji, I ; Christensen, J R ; Christensen, M K B ; Hansen, V ; Illés, Zsolt ; Jensen, Henrik Boye ; Kant, Matthias ; Petersen m.fl., T. . / Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis: a nationwide cohort study. Poster session presented at ECTRIMS 2019, Stockholm, Sweden.
@conference{a8ef1050945b4ee195f66a1a306495ca,
title = "Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis:: a nationwide cohort study",
author = "Buron, {Mathias Due} and Chalmer, {Thor Ameri} and I Barzinji and Christensen, {J R} and Christensen, {M K B} and V Hansen and Zsolt Ill{\'e}s and Jensen, {Henrik Boye} and Matthias Kant and {Petersen m.fl.}, T.",
year = "2019",
month = "9",
day = "12",
language = "English",
note = "null ; Conference date: 11-09-2019 Through 13-09-2019",
url = "https://www.ectrims-congress.eu/2019.html",

}

Buron, MD, Chalmer, TA, Barzinji, I, Christensen, JR, Christensen, MKB, Hansen, V, Illés, Z, Jensen, HB, Kant, M & Petersen m.fl., T 2019, 'Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis: a nationwide cohort study', ECTRIMS 2019, Stockholm, Sweden, 11/09/2019 - 13/09/2019.

Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis: a nationwide cohort study. / Buron, Mathias Due; Chalmer, Thor Ameri; Barzinji, I; Christensen, J R; Christensen, M K B; Hansen, V; Illés, Zsolt; Jensen, Henrik Boye; Kant, Matthias; Petersen m.fl., T. .

2019. Poster session presented at ECTRIMS 2019, Stockholm, Sweden.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

TY - CONF

T1 - Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis:

T2 - a nationwide cohort study

AU - Buron, Mathias Due

AU - Chalmer, Thor Ameri

AU - Barzinji, I

AU - Christensen, J R

AU - Christensen, M K B

AU - Hansen, V

AU - Illés, Zsolt

AU - Jensen, Henrik Boye

AU - Kant, Matthias

AU - Petersen m.fl., T.

PY - 2019/9/12

Y1 - 2019/9/12

M3 - Poster

ER -

Buron MD, Chalmer TA, Barzinji I, Christensen JR, Christensen MKB, Hansen V et al. Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis: a nationwide cohort study. 2019. Poster session presented at ECTRIMS 2019, Stockholm, Sweden.